Table 2.
Details of antidepressant treatments among non-remitters and remitters prior to and during study period.
| Remitters N (%) | Non-Remitters N (%) | Fisher’s exact or t-test | |
|---|---|---|---|
| # previously treated with antidepressant medications | 5 (71.4) | 8 (66.7) | 1 |
| Med-free days prior to enrollment for non-med-naïve subjects | 23.6 ± 8.8 | 72 ± 119.1 | .39 |
| Treatment intensity (ATHF1) | 2.71 ± 1.7 | 3.08 ± 1.3 | .60 |
| On meds at 1 year | 6 (85.7) | 8 (61.5) | .60 |
| Exposure to: | |||
| Selective serotonin reuptake inhibitor | 4 (57.1) | 9 (75) | .62 |
| Tricyclic antidepressant | 1 (14.3) | 1 (7.7) | 1 |
| Monoamine oxidase inhibitor | 0 (0) | 1 (8.3) | 1 |
| Bupropion | 2 (28.6) | 4 (33.3) | 1 |
| Venlafaxine | 1 (14.3) | 3 (25) | 1 |
| Lithium | 3 (42.9) | 1 (8.3) | .12 |
| Thyroid | 1 (14.3) | 1 (8.3) | 1 |
| ECT | 0 (0) | 0 (0) | 1 |
| Psychotherapy | 8 (67.7) | 5 (71.4) | 1 |
1
antidepressant treatment history form